Centogene regains compliance with nasdaq listing requirements

Cambridge, mass. and rostock, germany and berlin, july 14, 2023 (globe newswire) -- centogene n.v. (nasdaq: cntg) (the “company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that it has received notifications from the nasdaq stock market llc (“nasdaq”) listing qualifications department informing the company that it has regained compliance with the minimum bid price requirement for continued listing on the nasdaq under nasdaq listing rule 5450(a)(1) and with the minimum market value of publicly held shares (“mvphs”) requirement for continued listing on the nasdaq under nasdaq listing rules 5450(b)(3)(c).
CNTG Ratings Summary
CNTG Quant Ranking